发明名称 |
PHARMACEUTICAL COMPOSITIONS COMPRISING 40 - O - ( 2 - HYDROXY) ETHYL - RAPAMYCIN |
摘要 |
The invention relates to extended release pharmaceutical formulations in form of multiparticulates comprising 40-O-(2-hydroxy)ethyl-rapamycin, to dosage forms which comprise said pharmaceutical formulations, to methods of preparing said pharmaceutical formulations and said dosage forms, to uses of said pharmaceutical formulations and said dosage for the manufacture of a medicament for the treatment or prevention of diseases or conditions responsive to inhibition of mTOR signaling pathway, such as for instance proliferative diseases or immunosuppression. |
申请公布号 |
US2017049754(A1) |
申请公布日期 |
2017.02.23 |
申请号 |
US201615345498 |
申请日期 |
2016.11.07 |
申请人 |
Novartis AG |
发明人 |
DIEDERICH Anke;LIECHTI Kurt;KUEHL Peter;CHEUNG Wing |
分类号 |
A61K31/436;A61K9/48;A61K9/28;A61K9/00;A61K9/20 |
主分类号 |
A61K31/436 |
代理机构 |
|
代理人 |
|
主权项 |
1. An extended release pharmaceutical formulation for oral administration in form of a multi particulate comprising a) 40-O-(2-hydroxy)ethyl-rapamycin, b) at least one extended release coating which comprises a water insoluble coat forming polymer and c) a protection layer, wherein the protection layer separates a layer comprising the 40-O-(2-hydroxy)ethyl-rapamycin from the extended release coating. |
地址 |
Basel CH |